Japan
# |
Name |
Capital Expenditure |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD -545.06 M
|
March 31, 2024 | USD 9.47 | 0.08% |
|
Japan |
|
2 |
USD -186.76 M
|
March 31, 2024 | USD 14.33 | -1.63% |
|
Japan |
|
3 |
USD -70.61 M
|
March 31, 2024 | USD 9.54 | -0.95% |
|
Japan |
|
4 |
USD -13.84 M
|
March 31, 2024 | USD 3.51 | 6.45% |
|
Japan |
|
5 |
USD -12.11 M
|
March 31, 2024 | USD 24.50 | -0.22% |
|
Japan |
|
6 |
USD -9.70 M
|
Dec. 31, 2023 | USD 12.89 | -3.06% |
|
Japan |
|
7 |
USD -5.12 M
|
March 31, 2024 | USD 11.63 | 0.67% |
|
Japan |
|
8 |
USD -1.91 M
|
Dec. 31, 2023 | USD 9.57 | -3.49% |
|
Japan |
|
9 |
USD -1.65 M
|
Dec. 31, 2023 | USD 1.21 | -0.50% |
|
Japan |
|
10 |
USD -1.57 M
|
Dec. 31, 2023 | USD 2.63 | -0.70% |
|
Japan |
|
11 |
USD -90.89 K
|
June 30, 2024 | USD 1.01 | 1.37% |
|
Japan |
|
12 |
USD -50.53 K
|
March 31, 2024 | USD 0.28 | 0.04% |
|
Japan |
|
13 |
USD -40.30 K
|
Dec. 31, 2023 | USD 3.76 | 2.75% |
|
Japan |
|
14 |
USD -17.36 K
|
March 31, 2024 | USD 0.17 | 0.04% |
|
Japan |
|
15 |
USD 0.00
|
March 31, 2024 | USD 0.92 | -1.38% |
|
Japan |
The Vaccines company in Japan with the highest Capital Expenditure is Astellas Pharma Inc. (Tokyo Stock Exchange: 4503.T) at USD -545.06 M.
The Vaccines company in Japan with the lowest Capital Expenditure is NanoCarrier Co., Ltd. (Tokyo Stock Exchange: 4571.T) at USD 0.00.
The top 10 Vaccines companies in Japan by Capital Expenditure are Astellas Pharma Inc., Shionogi & Co., Ltd., Santen Pharmaceutical Co., Ltd., JCR Pharmaceuticals Co., Ltd., Kissei Pharmaceutical Co., Ltd., PeptiDream Inc., WDB Holdings Co., Ltd., Mizuho Medy Co.,Ltd., SymBio Pharmaceuticals Limited and RaQualia Pharma Inc..
The bottom 10 Vaccines companies in Japan by Capital Expenditure are NanoCarrier Co., Ltd., OncoTherapy Science, Inc., Oncolys BioPharma Inc., BrightPath Biotherapeutics Co., Ltd., Soiken Holdings Inc., RaQualia Pharma Inc., SymBio Pharmaceuticals Limited, Mizuho Medy Co.,Ltd., WDB Holdings Co., Ltd. and PeptiDream Inc..